Understanding Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome (CHS) is an increasingly recognized but frequently misdiagnosed condition associated with chronic cannabis use, characterized by cyclic vomiting and severe abdominal pain. As cannabis potency continues to rise and public perception shifts toward normalization, clinicians across medical and behavioral health settings encounter CHS with greater frequency. This training will provide a comprehensive overview of CHS, including its pathophysiology, diagnostic criteria, and distinguishing features from other gastrointestinal and psychiatric conditions. Participants will also explore how cannabis potency, patterns of use, and co-occurring disorders impact the development and course of CHS. Emphasis will be placed on evidence-based assessment strategies, effective patient and family education, and interdisciplinary approaches to treatment.